Glovista Investments’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,050
Closed -$254K 88
2021
Q2
$254K Hold
2,050
0.06% 98
2021
Q1
$242K Hold
2,050
0.07% 96
2020
Q4
$240K Hold
2,050
0.08% 105
2020
Q3
$213K Sell
2,050
-1,135
-36% -$114K 0.08% 92
2020
Q2
$292K Buy
3,185
+485
+18% +$46.5K 0.11% 72
2020
Q1
$243K Sell
2,700
-400
-13% -$42.6K 0.13% 77
2019
Q4
$352K Hold
3,100
0.12% 77
2019
Q3
$337K Hold
3,100
0.12% 74
2019
Q2
$302K Hold
3,100
0.1% 85
2019
Q1
$282K Buy
3,100
+200
+7% +$17.9K 0.09% 73
2018
Q4
$264K Buy
+2,900
New +$271K 0.07% 78

Other funds holding MDT

Glovista Investments's MDT Position: Q3 2021 in Review

Glovista Investments sold out of Medtronic (MDT) in Q3 2021, closing a stake of 2,050 shares — an estimated $254K sold.

Glovista Investments first reported a position in MDT in Q4 2018 and held it in 11 quarters. The position peaked at $352K in Q4 2019. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

  • Glovista Investments reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
  • Glovista Investments sold 2,050 Medtronic shares in Q3 2021, an estimated $254K.
  • Glovista Investments first reported a position in Medtronic in Q4 2018 and held it in 11 quarters.
  • Glovista Investments's Medtronic position peaked at $352K in Q4 2019.
  • 2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Glovista Investments's 13F filing for Q3 2021, filed 12 Nov 2021.